Business
Pfizer asks FDA to authorize third dose for children 5 to 11 years old
Sandra Hughes prepares to give the first dose of Pfizer-BioNTech coronavirus (COVID-19) vaccine to Elise Langevina, 6, in Storrs, Connecticut, U.S., November 3, 2021.
Michelle McLoughlin | Reuters
Pfizer on Tuesday asked the Food and Drug Administration for permission to give a third dose of the Covid vaccine to children aged 5 to 11.
The application comes after Pfizer released clinical trial data earlier this month showing that blood samples from 30 children in this age group had a 36-fold increase in antibody levels against the omicron variant compared with two doses of the vaccine. .
This is breaking news. Please check back for updates.